Source:http://linkedlifedata.com/resource/pubmed/id/11606426
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2001-10-18
|
pubmed:abstractText |
The gonadal steroid 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP) is a neuroactive steroid with anxiolytic and analgesic actions. In addition, 3 alpha HP has been shown to inhibit GnRH activity on gonadotropes and selectively suppress FSH release from pituitary cells, without an effect on LH. The enzyme 3 alpha-hydroxysteroid dehydrogenase (3 alpha HSD) has been presumed to be the enzyme responsible for the conversion of progesterone to 3 alpha HP, but this has never been confirmed in vitro or in vivo. We have now determined the mechanism of 3 alpha HP synthesis in vivo using specific enzyme inhibitors and in vitro using recombinant proteins. Incubation of [(3)H]progesterone with purified recombinant rat and human 3 alpha HSD isoforms showed that both the rat 3 alpha HSD and the human type 2(brain) 3 alpha HSD converted progesterone to 3 alpha HP. Age-dependent 3 alpha HP production was demonstrated in pituitary and cortex. Incubation of both tissues with indomethacin, a known 3 alpha HSD inhibitor, decreased the conversion of progesterone to 3 alpha HP by at least 70%, indicating that 3 alpha HSD was responsible for this conversion. As human type 2 3 alpha HSD is expressed in a region-specific fashion in the brain, 3 alpha HP may only be made in specific regions of the brain. Furthermore, the data suggest that the pituitary has the capacity for 3 alpha HP production, which may provide an additional mechanism for regulation of GnRH action.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/20-alpha-Dihydroprogesterone,
http://linkedlifedata.com/resource/pubmed/chemical/3-Hydroxysteroid Dehydrogenases,
http://linkedlifedata.com/resource/pubmed/chemical/3-alpha-Hydroxysteroid...,
http://linkedlifedata.com/resource/pubmed/chemical/3-hydroxypregn-4-en-20-one,
http://linkedlifedata.com/resource/pubmed/chemical/Cholestenone 5 alpha-Reductase,
http://linkedlifedata.com/resource/pubmed/chemical/Enzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Fluoxetine,
http://linkedlifedata.com/resource/pubmed/chemical/Follicle Stimulating Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Uptake Inhibitors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0013-7227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
142
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4617-22
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11606426-20-alpha-Dihydroprogesterone,
pubmed-meshheading:11606426-3-Hydroxysteroid Dehydrogenases,
pubmed-meshheading:11606426-3-alpha-Hydroxysteroid Dehydrogenase (B-Specific),
pubmed-meshheading:11606426-Animals,
pubmed-meshheading:11606426-Cholestenone 5 alpha-Reductase,
pubmed-meshheading:11606426-Enzymes,
pubmed-meshheading:11606426-Female,
pubmed-meshheading:11606426-Fluoxetine,
pubmed-meshheading:11606426-Follicle Stimulating Hormone,
pubmed-meshheading:11606426-Humans,
pubmed-meshheading:11606426-Oxidoreductases,
pubmed-meshheading:11606426-Rats,
pubmed-meshheading:11606426-Rats, Sprague-Dawley,
pubmed-meshheading:11606426-Recombinant Proteins,
pubmed-meshheading:11606426-Serotonin Uptake Inhibitors,
pubmed-meshheading:11606426-Tissue Distribution
|
pubmed:year |
2001
|
pubmed:articleTitle |
Biosynthesis of the neurosteroid 3 alpha-hydroxy-4-pregnen-20-one (3 alpha hp), a specific inhibitor of FSH release.
|
pubmed:affiliation |
Department of Neurology, University of California, San Francisco, California 94143, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|